Details
Structure visualisation
Entry information
| Complex | |
| AACDB_ID: | 581 |
| PDBID: | 3LHP |
| Chains: | IM_T |
| Organism: | Homo sapiens, synthetic construct |
| Method: | XRD |
| Resolution (Å): | 2.70 |
| Reference: | 10.1016/j.str.2010.06.010 |
| Antibody | |
| Antibody: | 4E10 Fv |
| Antibody mutation: | No |
| INN (Clinical Trial): | |
| Antigen | |
| Antigen: | HIV epitope-scaffold 4E10_D0_1ISEA_004_N (T93) |
| Antigen mutation: | No |
| Durg Target: | |
Sequence information
Antibody
Heavy Chain: I
Mutation: NULL
| >3LHP_I|Chain A[auth H], B[auth I]|Fv 4E10 heavy chain|Homo sapiens (9606) GSQVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGAGWLGKPIGAFAHWGQGTLVTVSSLEHHHHHH |
Light Chain: M
Mutation: NULL
| >3LHP_M|Chain C[auth L], D[auth M]|Fv 4E10 light chain|Homo sapiens (9606) MAEIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKLVPR |
Antigen
Chain: T
Mutation: NULL
| >3LHP_T|Chain E[auth S], F[auth T]|4E10_D0_1ISEA_004_N (T93)|Artificial gene (32630) HHHHHHGSISDIRKDAEVRMDKAVEAFKNKLDKFKAAVRKVFPTEERIKDWLKIVRGEAEQARVAVRNVGRDANDKAAALGKDKEINWFDISQSLWDVQKLTDAAIKKIEAALADMEAWLTQG |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
| I: THR31 TYR32 ALA33 SER35 TRP47 GLY50 ILE52 LEU54 LEU55 ILE57 THR58 ASN59 GLU99 LEU107 GLY108 LYS109 PRO110 GLY112 PHE114 M: ASN31 LYS33 TYR92 GLY93 GLN94 SER95 SER97 T: ASN74 ASP75 ALA78 GLY81 ILE86 ASN87 TRP88 PHE89 ASP90 ILE91 SER92 GLN93 LEU95 TRP96 GLN99 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)
